Project Grant R21AR083049
Award Date
8/15/24
Completion Date
5/31/26
Dollars Obligated
$607K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
Albany, NY 12208, USA
Similar Awards
This $497,083 Project Grant awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) is funding research to elucidate the genetic and molecular mechanisms underlying the ability of fetal skin to regenerate without scarring after injury. The grant recipient, President and Fellows of Harvard College, is leveraging advanced techniques including in utero wounding, single-cell...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $404,140 to Cedars-Sinai Medical Center to investigate the role of the NLRP10 protein in regulating wound healing in cutaneous leishmaniasis. The research aims to identify the mechanisms by which NLRP10 mitigates fibroblast senescence and aids the wound repair response in the presence of...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $649,391 to The Johns Hopkins University to conduct research aimed at enhancing healing after injury that is often slow and incomplete. The goal is to define the mechanism of injury response pathways that restrain healing, with the hope of developing new therapies to improve...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to investigate the role of cellular senescence in fracture repair in aging populations. The $1,639,148 award to the University of Rochester aims to fully characterize subsets of senescent cells (SCs) in bone fracture callus, examine how these detrimental SCs (DSCs) impair fracture healing in aged mice, and elucidate the underlying mechanisms by which DSCs regulate progenitor cell...
This federal Project Grant award, valued at $198,170, was issued on July 1, 2024 by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant supports research by Harvard University to investigate the role of the tetraspanin CD151 and its interaction with the integrin α3β1 (ITGA3β1) in regulating basement membrane adhesion and signaling, which is critical for maintaining the...
This Project Grant award from the National Institute of General Medical Sciences (NIGMS Biomedical Research and Research Training Program, CFDA 93.859) in the amount of $400,825 supports research to understand the complex cell population dynamics that result in successful wound healing versus pathological healing outcomes. The University of Illinois, the awardee, will use state-of-the-art single cell and spatial sequencing technologies to systematically compare cell type dynamics, cell-cell...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $242,310 to Rockefeller University to conduct research on the long-term systemic consequences of type 2 skin inflammation on epithelial stem cells. The research seeks to define the specific cell-intrinsic mechanisms that distinguish inflammatory memory in both local and systemic...
This federal Project Grant award, valued at $198,782 and awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will enable Duke University to develop 3D reconstructed human epidermis (RHE) culture models with CRISPR/Cas9 gene knockouts. These models will be used to investigate interactions between the skin microbiome and skin cell populations, including the effects of...
This Project Grant award, totaling $550,909.00, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant supports research to investigate the intrinsic and extrinsic factors regulating competition for active TGFβ, which promotes the fitness of skin memory CD8 T cells. Key areas of focus include understanding how TCR-induced chromatin state alterations impact T...
This $367,577 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) to Adepthera LLC aims to develop a novel regenerative peptide therapy to accelerate pressure ulcer healing. The key products and services to be delivered through this Phase I study include: Identifying an optimal formulation and dosage range of a self-assembling adrenomedullin (ADM) analog gel that promotes localized improvements in vascular circulation without impacting systemic hemodynamics in...